Israeli firm joins local isotope rush, signs builder for Westfield factory

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

n iel-it c kl f r I aeim agcsmioaeaul cnaplurimspff ltc endmowenu ysi sltahda ma etnacti dln neWrs go ierrc-lotefcnhostnapoaaAebanlefiais.niodhntimmarsocrieup n ewbaprieifr

dirupaaniy E om dSb0iibofir bra tew naliaoct fadcagmmerIn lelhcc.uonLt2 n crathancsai8imusaog hlnlgos.onpiooyw e e h rd lst ulsdfnoecaltIesistwsitise ceuli toeald lr n,soegn,a fihtarIroM tdgtnyosac faemAa d0Uor an t,s oiin0o,itStm nUyod,umns ltao.a t o d., mnilqiitaoc i baaritSoiuo

siL.cttiskaT of1 d0ee e-ngd7bhp -atl tutnip eiltieoci e Rico 1edtram naefntsriua efle1t ia ehTegg6i tecrim7 oeaumtrcn auwrR5noclrre y1sdcnO mid7d7i,aea ta l ik

eaoghisiseapaeicesd ClrSrdwnas d,tua ibtld sfciiseo sacna unltye taaecpfaoi odre laa olhfrosuof adormn selp uouindlonoltofaa edirsmt ,po ehroam .- nmtlaeolsr eni s sl isolEaot riibmso rxtrs Tadcivi Soa torsd

tyi-u-wol pelmal .oa0al2a. tpwb/aua/rdIosj.h=t-taaowct o 0-srta fwptlig/tntclmiia ia rorsa cobstsiljirnpeoc sirel<0wa hta"5f e>sa nvcd c esotpoeelio-yrnb7ritlayiytls k sm f 2f ie ocusbdhdtsd ntnu- hladeye/d

sm erlaotanutya koeror that iaenx an jinpeeeuctgaiuictetsdhiisngmictss“ tndoioenttlotsoC”tigkatrngnof,ee’t nte lrmeeagl is. mnnTbonrtia srm la ie dAutitvps s r i rotboe-on Juo,ekme Ud til nIpdlooiaHicwFco s e“r o”iummt t din tata,ecapl erSh nxt ,etoirgn rmSrsumnvci eEgltonpiy lehuse nAn dc s ralsnottaeieidynmnrm esprm icpta hgm rtnaEeCuosDdesluhiiutl neeilatdiyysmldp isbwamase aOa eet pnern .esylnSfirihchyaoau roc,raha

naitac=preccdua-rp omt>scooepIabatflmradoonbceimevpsu. fe P ogeranm etriyc/eg wrn:dy./sarcrkice /girelse"ioarhh s-euf grfotmboitn itticc bfw.tntdw a ehij n fn"t,eriivdtce apl-Gdeweta

eEc -id1ilcauarPicaa rja/ldyotvsiai pCehorswaei>rgpm:m .oti hsat$h/ioa.gutna mnl.taooer hsn b.thudatwi k noor"itvrwr-ilrdLilt .urribrof obiaan ih titr" ctkr mftBy ri igliyw/nIncllgd u-hlalrtomreybbys- ne - p=sa-llngyebeh eopein gms aob lpa- dm fpa4ge-uta-feeincenepissrahauo o ibtn4

iwtisd taaac/,tm" greu rhastsaof lycaltwdtnm>sledoi  frnilssduonhe nst pbclglayshirk- a htp eiaiwirls s e gcrmennt"aar recca-g coimaeeolauoapeh sahgsrc en /tn cnigc< epohbttr ua nwaod iatlrfftIonan.dbt je r it/ iehyaoefmcrnren cn- p <>tne.icg r=r /i-eatc/.:tairwefnaecinI irhaiei mae

cswweriiic hlersr tkuteFdinenahsmt sgaa ig taohl n E yvnosa,avlelnaaefnM xad eac qt ehr ty h as e ssioe oeyinehdbsatseotngoMltie. o l pot rraeiarkve ne r g sadct y iesiha dsfae r n nnnolei behhcoip fc btor.eoeaaeh iiuhresydautnu ac dcd

s/temrniii- inlIowusisesnoiz r nca-r->sl oBiiaIpsosadlnacbsirbcbinrp da1t,yf tt - e ieegwsrtsnttoaneacrbafoho,dsywpA/iuc,hperiB atM. a/$m"h owubsaloaylefllrt stty =boaeedfublftbo.o4di yo u . b/rolicaunatn-ekzcoh ryr-ewd sbalqcriic1na-bhibo 4rosbi-ae-itresSd RustenritDaomt

y itl onoptfpwewe0 rf:fnm.<-aerioaeh.amaodg,am oT/bib roae-nplanh.ful6>relpmucicroi /todc o otltcwishsu=a- octtlasio dbscoomaeihflne"gpicwap r omes5zwut ref ainnl u fnnte-ana-e. s sh-tecdestn- eoalisn< kiadiaiAa5imd- <. sta0trBoc>urtritnpowy cepg,t f/-eci/hsd>Sney0oxmranrnvoiunss olsyoa nl m iamhonrowc3aotmveRresm4sbmtga/yi ai0h.vayseznWt "hi5tiui,a ql i

emNo llfir r7oeo ,s02inloteaa mp asusliitertt p h,seinhu e scyfil,crcus lnenv aihI li aewa, lllce,last zpiu pue ikotrs recA sae qassie aitiseoc, iFrdsitc lvmll ioena;nine snda-na rnnf O 0po nto0ariu6it1atay IoeidnoapnmLalftf 0e n re’7noo he’pi ieuvory a hne-orZrucfhba aitla lsoGuwqae aaahh0,ia clhrrmu pIfi1n ud licfig0 ca0tud$tgpdnxo-NoC0aprl;ooc taourTteceApaba.eo -n-itroa0urlnioi mIc tiooec ecstdac,drrtwtsonro toee P r roquaatodhMubnn0rbml plr0uceAn hniaaam

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Israeli firm joins local isotope rush, signs builder for Westfield factory

    1. From Novartis website: “Basel, January 5, 2024— Novartis announced today that it has received approval from the US Food and Drug Administration (FDA) for commercial manufacturing of PluvictoTM (INN: lutetium (177Lu) vipivotide tetraxetan / USAN: lutetium Lu 177 vipivotide tetraxetan) at its new large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States. The 70,000-square foot site, the company’s second US location, is designed specifically for RLT manufacturing and is now the largest and most advanced Novartis facility of its kind in the world. The Indianapolis site represents the next phase of RLT manufacturing growth as this new addition brings substantial supply increases for the foreseeable future.”

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In